Glycostasis, Inc.

Glycostasis has engineered a human protein to release insulin when blood glucose levels rise and bind it when glucose levels fall, mimicking the natural regulation of insulin in a healthy individual.  

Dr. John Mulligan, Ph.D.​

Founder and CEO

LinkedIn


Glucose-responsive insulin

Engineered insulin

Type I diabetes

Sensulin

Thermalin

Biocon